ORPEA

Earnings Release • Oct 27, 2009

PRESS RELEASE

Strong increase in Q3 2009 sales: +20.3% to €217.9m

Buoyant organic growth of +12.1%

Puteaux, 27th October 2009

ORPEA, a leading player in Long-Term Care (nursing homes), Post-Acute Care and Psychiatric Care, today announced its sales for the 3rd quarter ended 30th September 2009.

In €m IFRS	Quarterly			9 months
	Q3 2009	Q3 2008	Δ	2009	2008	Δ
France	190.0	156.5	+21.4%	542.7	450.6	+20.4%
% of total sales	87%	86%		87%	88%
International	28.0	24.6	+13.7%	78.3	60.7	+29.0%
% of total sales	13%	14%		13%	12%
Belgium	12.4	11.0		36.0	24.0
Spain	7.4	7.0		21.4	19.9
Italy	5.7	4.5		13.7	10.9
Switzerland	2.6	2.0		7.4	5.9
Total sales	217.9	181.1	+20.3%	621.1	511.3	+21.5%
Organic growth			+12.1%			+11.2%

Yves Le Masne, Deputy CEO, commented: "Third-quarter activity, up +20%, reaffirms the momentum that has been ORPEA's for almost 10 years now, with continuing buoyant, healthy and lasting growth. Organic growth, up 12.1%, even accelerated compared to the first half of the year.

The Group is fully confident that it will meet its targets: 2009 annual sales of €840m, 2011 sales of significantly over a billion euros and further solid profitability.

Following the optimisation of the Group's financial profile in recent months through the €217m OBSAAR bond issue and the €62.4m capital increase, ORPEA will pursue its development strategy, notably seizing strategic acquisition opportunities that arise, in order to further strengthen its position as a selective consolidator of the Care sector. Actively participating in a useful need for the community whilst creating value is, day in day out, a motivating action for all of the Group's teams."

Next Press Release: Full-year 2009 sales Tuesday 9th February 2010 before market opening

About ORPEA (www.orpea.com): Listed on Euronext Paris since April 2002 and recently promoted to the Deferred Settlement Service, the ORPEA group is a leading player in the Long-Term Care and Post-Acute Care sectors. As of September 2009, the Group has a unique European network of healthcare facilities, with 26,526 beds (21,565 of them operational) across 284 sites, including:

• 21,585 beds in France: 17,619 operational (including 3,021 being renovated) + 3,966 under construction, spread across 238 sites.

• 4,941 beds in Europe (Spain, Belgium, Italy and Switzerland): 3,946 operational (including 508 being renovated) + 995 under construction, spread across 46 sites.

Listed on Euronext Paris Compartment B of NYSE Euronext - ISIN: FR0000184798 Member of the SBF 120 index and SRD Reuters: ORP.PA - Bloomberg: ORP FP

Investor Relations

NewCap. ORPEA Emmanuel Huynh/Steve Grobet Yves Le Masne Tel: +33 (0)1 44 71 94 94 Deputy CEO orpea@newcap.fr Tel: +33 (0)1 47 75 78 07